The significance of subchondral bone in the pathogenesis of osteoarthritis;Význam subchondrální kosti v patogenezi osteoartrózy

Osteologicky Bulletin

Volumn 9, Issue 2, 2004, Pages 54-58

  Šenolt, Ladislav ^a   Pavelka, K ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

Cytokines; Eicosanoids; Microcraks; Neovascularization; Osteoarthritis; Proteolytic enzymes and growth factors; Subchondral bone

Indexed keywords

BIOCHEMICAL MARKER; CYTOKINE; GROWTH FACTOR; ICOSANOID; PROTEINASE;

ARTICLE; ARTICULAR CARTILAGE; BONE; BONE METABOLISM; BONE RADIOGRAPHY; CARTILAGE DEGENERATION; DISEASE COURSE; MEDIATOR RELEASE; NEOVASCULARIZATION (PATHOLOGY); OSSIFICATION; OSTEOARTHRITIS; OSTEOBLAST; OSTEOSCLEROSIS; PATHOGENESIS; RIGIDITY; SUBCHONDRAL BONE;

EID: 3342993498     PISSN: 12113778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Lawrence RC, Helmick GG, Arnett DF, et al. Estimates of the prevalence of arthritis and selected musculosceletal disorders in the United States. Arthritis Rheum 1998;41:778-788.
2. Brandt KD. Pathology. In: Brandt KD. Diagnosis and Nonsurgical Management of Osteoarthritis 2000;45-51.
3. Aigner T, Zien A, Hanisch D, Zimmer R. Gene expression in chondrocytes assessed with use of microarrays. J Bone Joint Surg Am. 2003; 85-A Suppl 2:117-23.
4. Aigner T, Kurz B, Fukui N, Sandell L. Roles of chondrocytes in the pathogenesis of osteoarthritis. Curr Opin Rheumatol 2002;14:578-84.
5. Westacott CI, Webb GR, Warnock MG, et al. Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum. 1997;40:1282-91.
6. Burr DB. The importance of subchondral bone in osteoarthrosis. Curr Opin Rheumatol 1998;10:256-62.
7. Lajeunesse D, Reboul P. Subchondral bone in osteoarthritis: a biologic link with articular cartilage leading to abnormal remodeling. Curr Opin Rheumatol 2003;15:628-33.
8. Dequeker J. Inverse relationship of interface between osteoporosis and osteoarthritis. J Rheumatol 1997:24:795-8.
9. Li B, Aspden RM. Mechanical and material properties of the subchondral bone plate from the femoral head of patients with osteoarthritis or osteoporosis. Ann Rheum Dis 1997;56:247-54.
10. Cheng XG, Nicholson PH, Lowet G, et al. Prevalence of trabecular microcallus formation in the vertebral body and the femoral neck. Calcif Tissue Int 1997;60:479-84.
11. Radin EL, Paul IL, Rose RM. Role of mechanical factors in pathogenesis of primary osteoarthritis. Lancet 1972;1:519-22.
12. Radin EL, Abemethy PJ, Townsend PM, Rose RM. The role of bone changes in the degeneration of articular cartilage in osteoarthrosis. Acta Orthop Belg 1978;44:55-63.
13. Radin EL, Parker HG, Pugh JW, et al. Response of joints to impact loading. 3. Relationship between trabecular microfractures and cartilage degeneration. J Biomech 1973;6:51-7.
14. Radin EL, Rose RM. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop 1986;213:34-40.
15. Casden AM, Jaffe FF, Kastenbaum DM, Bonar SF. Osteoarthritis associated with osteopetrosis treated by total knee arthroplasty. Report of a case. Clin Orthop 1989;247:202-7.
16. Dequeker J, Aerssens J, Luyten FP. Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship. Aging Clin Exp Res 2003; 15:426-39.
17. Burr DB, Radin EL. Microfractures and microcracks in subchondral bone: are they relevant to osteoarthrosis? Rheum Dis Clin North Am 2003;29:675-85.
18. Sokoloff L. Microcracks in the calcified layer of articular cartilage. Arch Pathol Lab Med 1993; 117:191-5.
19. Havelka&Horn. Observations on tidemark and calcified layer of articular caritlage, in: Archer and al, eds. Biology of the synovial joint. Amsterdam, Harwood Academic Publischers 1999:331-346.
20. Laufer S. Role of eicosanoids in structural degradation in osteoarthritis. Curr Opin Rheumatol 2003;15:623-7.
21. Wittenberg RH, Willburger RE, Kleemeyer KS, Peskar BA. In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Arthritis Rheum 1993;36:1444-50.
22. Massicotte F, Lajeunesse D, Benderdour M, et al. Can altered production of interleukin-1 beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage 2002;10: 491-500.
23. Paredes Y, Massicotte F, Pelletier JP, et al. Study of the role of leukotriene B 4 in abnormal function of human subchondral osteoarthritis osteoblasts: effects of cyclooxygenase and/or 5-lipoxygenase inhibition. Arthritis Rheum 2002;46:1804-12.
24. Pavelka K, Bias P, Buchner A, et al. Licofelone, a 5-lipoxygenase, cyclooxygenase-1 and -2 inhibitor, is as effective as celecoxib and shows improved tolerability in osteoarthritis of the knee. Osteoarthritis Cart 2003;11,supp.A,110:40.
25. Lajeunesse D, Martel-Pelletier J, Fernandes JC et al. Treatment with licofelone prevents abnormal subchondral bone cell metabolism in experimental dog osteoarthritis. Ann Rheum Dis 2004;63:78-83.
26. Hedbom E, Hauselmann HJ. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci 2002;59:45-53.
27. Hilal G, Martel-Pelletier J, Belletier JP, et al. Osteohlast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheum 1998;41:891-9.
28. Dore S, Pelletier JP, DiBattista JA, et al. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of 1GF-1-binding proteins. Arthritis Rheum 1994;37:253-63.
29. Dore S, Abribat T, Rousseau N, et al. Increased insulin-like growth factor 1 production by human osteoarthritic chondrocytes is not dependent on growth hormone action. Arthritis Rheum 1995;38:413-9.
30. Massicotte F, Lajeunesse D, Benderdour M, et al. Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage 2002;10:491-500.
31. Scharstuhl A, Vitters EL, van der Kraan PM, van den Berg WB. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 2003;48:3442-51.
32. Udagawa N, Kotake S, Kamatani N, et al. The molecular mechanism of osteoclastogenesis in rheumatoid arthritis. Arthritis Res 2002;4:281-9.
33. Fazzalari NL, Kuliwaba JS, Atkins GJ, et al. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. J Bone Miner Res 2001; 16:1015-27.
34. Komuro H, Olee T, Kuhn K, et al. The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage. Arthritis Rheum. 2001;44:2768-76.
35. Takemura M, Harada A, Mizuno M et al. Relationship between osteoprotegerin/osteoclastogenesis inhibitory factor concentration in synovial fluid and disease severity in individuals with osteoarthritis of the knee. Metabolism 2001;50:1-2.
36. Chagraoui H, Tulliez M, Smayra T et al. Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. Blood. 2003;101:2983-9.
37. Guevremont M, Martel-Pelletier J, Massicotte F, et al. Human adult chondrocytes express hepatocyte growth factor (HGF) isoforms but not HgF: potential implication of osteoblasts on the presence of HGF in cartilage. J Bone Miner Res 2003;18:1073-81.
38. Westacott CI, Webb GR, Warnock MG, et al. Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum 1997;40:1282-91.
39. Garnero P, Delmas PD. Biomarkers in osteoarthritis. Curr Opin Rheumatol 2003;15:641-6.
40. Gamero P, Piperno M, Gineyts E, et al. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001;60:545-8.
41. Bettica P, Cline G, Hart DJ, et al. Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. Arthritis Rheum 2002;46:3178-84.
42. Rovetta G, Monteforte P, Grignolo MC, et al. Hematic levels of type 1 collagen C-telopeptide in erosive versus nonerosive osteoarthritis of the hands. Int J Tissue React 2003;25:25-8.
43. Garnero P, Landewe R, Boers M, et al. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 2002;46:2847-56.
44. Kawabata TT. The potential of NE-58098, NE-10216, and EHDP to alter or prevent osteoarthritis (osteoarthrosis) in the Hartley guinea pig. Project number 995.80.00-BL. Final Report 1996, Accession No.45317.
45. Lehmann HJ, Mouritzen U, Christgau S, et al. Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type 11 degradation products. Ann Rheum Dis 2002;61:530-3.
46. Otterness IG, Swindell AC, Zimmerer RO, et al. An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis Cartilage 2000;8:180-5.
47. Otterness IG, Weiner E, Swindell AC, et al. An analysis of 14 molecular markers for monitoring osteoarthritis. Relationship of the markers to clinical end-points. Osteoarthritis Cartilage 2001;9:224-31.
48. Bruyere O, Collette JH, Ethgen O, et al. Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. J Rheumatol 2003;30:1043-50.
49. Bruyere O, Collette JH, Ethgen O, et al. Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. J Rheumatol 2003;30:910-2.
50. Šenolt L, Braun M, Pavelka K. Konečné produkty pokročilé glykace u pacientů s osteoartrózou a revmatoidní artritidou a jejich potenciální úloha v patogenezi těchto onemocnění. Čes Revmatol 2003;3:146-56.
51. Verzijl N, Bank RA, TeKoppele JM, DeGroot J. AGEing and osteoarthritis: a different perspective. Curr Opin Rheumatol 2003;15:616-22.
52. Wang X, Shen X, Li X, Agrawal CM. Age-related changes in the collagen network and toughness of bone. Bone 2002;31:1-7.
53. Paul RG, Bailey AJ. The effect of advanced glycation end-product formation upon cell-matrix interactions. Int J Biochem Cell Biol 1999;31:653-60.
54. Takagi M, Kasayama S, Yamamoto T, et al. Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells. J Bone Miner Res 1997;12:439-46.
55. Newberry WN, Zukosky DK, Haut RC. Subfracture insult to a knee joint causes alterations in the bone and in the functional stiffness of overlying cartilage. J Orthop Res 1997;15:450-5.
56. Huebner JL, Hanes MA, Beekman B, et al. A comparative analysis of bone and cartilage metabolism in two strains of guinea-pig with varying degrees of naturally occurring osteoarthritis. Osteoarthritis Cartilage 2002;10:758-67.
57. Gannon FH, Sokoloff L. Histomorphometry of the aging human patella: histologic criteria and controls. Osteoarthritis Cartilage 1999;7:173-81.